US FDA declines Moderna flu vaccine review amid vaccine guidance rollback
12 February 2026, 08:15
CEO Stephane Bancel said the letter refusing review did not cite 'any safety or efficacy concerns'.
CEO Stephane Bancel said the letter refusing review did not cite 'any safety or efficacy concerns'.
Comments (0)
Do you like the page?
Would you like to share the page with your friends?